As ICI and chemoradiation directly or indirectly target T cells regardless of their specificity, we simulated global T cell activation using microbeads loaded with anti-CD2/CD3/CD28 antibodies (referred to as microbeads) in the third CRC patient cohort (Figure 6A–D). The gene discussed is CD2; the disease is colorectal carcinoma.